The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

Boursier, Jérôme, Mueller, Olaf, Barret, Matthieu, Machado, Mariana, Fizanne, Lionel, Araujo‐Perez, Felix, Guy, Cynthia D., Seed, Patrick C. +6 more·2016·Hepatology

Cited by (1,000)

Items 801–900 of 1,000

  1. Correlation between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction in non-obese adults: a cross-sectional study
    Fangyuan Cong, Luying Zhu, Lihua Deng, Qian Xue, Jingtong Wang · 2023 · BMC Gastroenterology
  2. Nutritional and Lifestyle Therapy for NAFLD in People with HIV
    Felice Cinque, Annalisa Cespiati, Rosa Lombardi, Giovanni Guaraldi, Giada Sebastiani · 2023 · Nutrients
  3. Protein kinases: The key contributors in pathogenesis and treatment of nonalcoholic fatty liver disease-derived hepatocellular carcinoma
    Rong Liu, Mingping Qian, Ying‐Yu Cui · 2023 · Metabolism
  4. Honokiol affects the composition of gut microbiota and the metabolism of lipid and bile acid in methionine-choline deficiency diet-induced NASH mice
    Ting Zhai, Junjun Wang, Yong Chen · 2023 · Scientific Reports
  5. Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
    Stanislav Gruzdev, Irina Viktorovna Podoprigora, Oksana Anatolievna Gizinger · 2024 · Archives of Microbiology
  6. Integrated analysis of metabolomic and gut microbiota reveals idiosyncratic drug-induced liver injury resulting from the combined administration of bavachin and icariside II
    Bo Cao, Yingying Li, Mengmeng Lin, Jing Xu, Taifeng Li, Xiaofei Fei, Xiaohe Xiao, Guohui Li, Chunyu Li · 2024 · Acupuncture and Herbal Medicine
  7. Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001–2023)
    Xiaofei Zhu, Ziyuan Zhou, Xiaxia Pan · 2024 · Frontiers in Microbiology
  8. Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth Comparison
    Milena N. Vesković, Milka Pejović, Nikola Šutulović, Dragan Hrnčić, Aleksandra Rašić-Marković, Olivera P. Stanojlović, Dušan R. Mladenović · 2024 · International Journal of Molecular Sciences
  9. Liver metabolism in human MASLD: A review of recent advancements using human tissue metabolomics
    Emily L. Flam, Joel T. Haas, Bart Staels · 2024 · Atherosclerosis
  10. Gas Chromatography-Mass Spectrometry (GC-MS) Analysis of the Volatile Oil of Cichorium Glandulosum Boiss et Huet and its Effects on Carbon Tetrachloride-Induced Liver Fibrosis in Rats
    Dongmei Qin, Xin-Bing Wang, Nan Zou, Chang Lung Han, Jia Li Xu · 2019 · Medical Science Monitor
  11. Veillonella Bacteremia in Alcoholic Hepatitis
    Patrick C. Lee, Brandon K.K. Fields, Tom Z. Liang, Michael P. Dubé, Seth Anthony Politano · 2021 · Case Reports in Hepatology
  12. NAD metabolic therapy in metabolic dysfunction-associated steatotic liver disease: Possible roles of gut microbiota
    Xinyi Lu, Rui Yang, Yu Chen, Daozhen Chen · 2024 · iScience
  13. Plant polyphenols delay aging: A review of their anti-aging mechanisms and bioavailability
    Hao Zhang, Feijie Wang, Li Wang, Jun Du, Yan Li · 2025 · Food Research International
  14. Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics
    Himani Pandey, Prabudh Goel, Varunvenkat M. Srinivasan, Daryl W. T. Tang, Sunny H Wong, Devi Lal · 2025 · World Journal of Hepatology
  15. Targeting gut microbiota in non-alcoholic fatty liver disease (NAFLD): Pathogenesis and therapeutic insights: A review
    Shuhao Bian, Shuyao Zhu, Jiaxu Lu, Mudassar Iqbal, Tariq Jamil, Faisal Ayub Kiani, Haiju Dong, Hongyu Dai, Xiangqian Zhang, Fang Liu et al. · 2025 · International Journal of Biological Macromolecules
  16. Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery
    José Ignacio Martínez‐Montoro, Mohammad Shafi Kuchay, Andrés Balaguer Román, María Antonia Martínez‐Sánchez, María Dolores Frutos, José Carlos Fernández‐García, Bruno Ramos‐Molina · 2021 · Obesity Reviews
  17. Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota
    Junbin Yan, Yunmeng Nie, Yuan Liu, Jingya Li, Liyan Wu, Zhiyun Chen, Beihui He · 2022 · Frontiers in Cellular and Infection Microbiology
  18. Nutrition and Microbiome
    Nathalie M. Delzenne, Julie Rodriguez · 2022 · Handbook of experimental pharmacology
  19. Hepatoprotective Effects of Ixeris chinensis on Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice: An Integrated Gut Microbiota and Metabolomic Analysis
    Wenjie Jin, Sungbo Cho, Namujila Laxi, Terigele Bao, Lili Dai, Hongzhen Yu, Rigeer Qi, Junqing Zhang, Genna Ba, Minghai Fu · 2022 · Molecules
  20. Beneficial effects of Lactobacillus rhamnosus hsryfm 1301 fermented milk on rats with nonalcoholic fatty liver disease
    Dawei Chen, Yating Liang, Jiaojiao Liang, Feifei Shen, Yue Cheng, Hengxian Qu, Yunchao Wa, Congcong Guo, Ruixia Gu, Jianya Qian et al. · 2023 · Journal of Dairy Science
  21. Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis
    Yoichi Takimoto, Po–Sung Chu, Nobuhiro Nakamoto, Yuya Hagihara, Yohei Mikami, Kentaro Miyamoto, Rei Morikawa, Toshiaki Teratani, Nobuhito Taniki, Sota Fujimori et al. · 2023 · iScience
  22. The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal Women
    Johanna Kay DiStefano · 2023 · Nutrients
  23. miR-27b targets MAIP1 to mediate lipid accumulation in cultured human and mouse hepatic cells
    Eiko Sakai, Tsutomu Imaizumi, Ruruka Suzuki, Marcos Taracena-Gándara, Toshiki Fujimoto, Fuminori Sakurai, Hiroyuki Mizuguchi · 2023 · Communications Biology
  24. Beneficial effects of silibinin on serum lipids, bile acids, and gut microbiota in methionine-choline-deficient diet-induced mice
    Wei J. Wang, Ting Zhai, Ping Luo, Xiaolei Miao, Junjun Wang, Yong Chen · 2023 · Frontiers in Nutrition
  25. Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Sara Abdollahiyan, Ali Nabavi-Rad, Shahrbanoo Keshavarz Azizi Raftar, Magali Monnoye, Naghmeh Salarieh, Azam Farahanie, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Behzad Hatami, Philippe Gérard et al. · 2023 · Scientific Reports
  26. Liver cirrhosis and complications from the perspective of dysbiosis
    Guole Nie, Honglong Zhang, Danna Xie, Jun Yan, Xun� Li · 2024 · Frontiers in Medicine
  27. Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients
    Qing-Yu Xiao, Ren-Ling Wang, Hai-Jun Wu, Wen-Bin Kuang, Wei-Wei Meng, Zhen Cheng · 2024 · Journal of Multidisciplinary Healthcare
  28. The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies
    Li Jun Wang, Jian Sun, Shu‐Cheng Chen, Youlan Sun, Yang Zheng, Jian Chao Feng · 2025 · Frontiers in Medicine
  29. Compromised nutritional status in patients with end-stage liver disease: Role of gut microbiota
    Maria Vasco, Rossella Paolillo, Concetta Schiano, Linda Sommese, Oreste Cuomo, Claudio Napoli A · 2018 · Hepatobiliary & pancreatic diseases international
  30. Gut Microbiota and Liver Injury (I)—Acute Liver Injury
    Guangyan Wu, Sanda Win, Tin Aung Than, Peng Chen, Neil Kaplowitz · 2020 · Advances in experimental medicine and biology
  31. Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulation
    Qi Li, Wanlin Dai, Jing Kong, Yu Tian, Yongsheng Chen · 2021 · Journal of Physiology and Biochemistry
  32. Identification cholesterol metabolites altered before the onset of nonalcoholic steatohepatitis by targeted metabolomics
    Saori Shoji, Masamitsu Maekawa, Jiro Ogura, Toshihiro Sato, Nariyasu Mano · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  33. Retrorsine Cooperates with Gut Microbiota to Promote Hepatic Sinusoidal Obstruction Syndrome by Disrupting the Gut Barrier
    Xiao Li, Lilin Hu, Huikuan Chu, Liuying Chen, Jingjing Yan, Weijun Wang, Xiaoqian Yang, Qingjing Zhu, Fan Du, Yuhu Song et al. · 2022 · Journal of Clinical and Translational Hepatology
  34. Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis
    Tian Lan, Tonghao Xu, Yanfang Fu, Shuo Jiang, Xiaolin Liang, Ze Yu, Linyu Pan, Xianglu Rong, Jiao Guo · 2022 · Frontiers in Endocrinology
  35. Metabolites, gene expression, and gut microbiota profiles suggest the putative mechanisms via which dietary creatine increases the serum taurine and g-ABA contents in Megalobrama amblycephala
    Yizhuo Hua, Wangwang Huang, Fan Wang, Jing Zhao, Juntao Li, Qingchao Wang, Yuhua Zhao · 2023 · Fish Physiology and Biochemistry
  36. Gut Microbiota in Health and Disease
    Edward E. Ishiguro, Natasha Haskey, Kristina Campbell · 2018 · Elsevier eBooks
  37. Microbial Infections as a Trigger for Acute-on-Chronic Liver Failure: A Review
    Qun Cai, Wei Liu, Mingyan Zhu, Jifang Sheng · 2019 · Medical Science Monitor
  38. Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension
    Keiji Yokoyama, Naoaki Tsuchiya, Ryo Yamauchi, Takashi Miyayama, Yotaro Uchida, Kumiko Shibata, Hiromi Fukuda, Kaoru Umeda, Kazuhide Takata, Takashi Tanaka et al. · 2020 · Internal Medicine
  39. Targeting gut microbiota and metabolism profiles with coated sodium butyrate to ameliorate high-energy and low-protein diet-induced intestinal barrier dysfunction in laying hens
    Sasa Miao, Jiankui Li, Ying Chen, Wenyan Zhao, Mengru Xu, Fang Liu, Xiaoting Zou, Xin Dong · 2024 · Animal nutrition
  40. Akebia trifoliata extracts attenuate liver injury via gut–liver axis in a murine model of nonalcoholic fatty liver disease with low-grade colitis
    Xiaoya Wang, Han Chen, Weifeng Zhu, Zhongliang Wang, Yao Pan, Yong Sun, Hua Xiong, Junmei Zhou, Wenliang Cheng, Kejun Cheng · 2025 · Food Research International
  41. Intestinal bacteria-derived extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From mechanisms to therapeutics
    Li-Na Qin, Yunfeng Yu, Lie Ma, Rong Yu · 2025 · Molecules and Cells
  42. Crosstalk Between Microbiome and Ferroptosis in Diseases: From Mechanism to Therapy
    Si‐Qi Ding, Yun Lei, Zhe‐Ming Zhao, Xin‐Yun Li, Ji‐Xuan Lang, Jia‐Kui Zhang, Yanan Li, Chun‐Dong Zhang, Dong‐Qiu Dai · 2025 · Comprehensive physiology
  43. Gut microbiota heterogeneity in non-alcoholic fatty liver disease: a narrative review of drivers, mechanisms, and clinical relevance
    Ying Guo, Naisi Zhang, Dongmei Pei · 2025 · Frontiers in Microbiology
  44. Microbiota reprogramming for treatment of alcohol-related liver disease
    Mohamed Tausif Siddiqui, Gail Cresci · 2020 · Translational research
  45. Metabolic dysfunction-associated fatty liver disease: advances in genetic and epigenetic implications
    Carlos J. Pirola, Silvia Sookoian · 2021 · Current Opinion in Lipidology
  46. Hepatoprotective Effect of Cereal Vinegar Sediment in Acute Liver Injury Mice and Its Influence on Gut Microbiota
    Qijie Guan, Tingting Gong, Zhen‐Ming Lu, Yan Geng, Wenhui Duan, Yilin Ren, Xiaojuan Zhang, Li‐Juan Chai, Jin‐Song Shi, Zhenghong Xu · 2021 · Frontiers in Nutrition
  47. Efficacy of Biejiajian Pill on Intestinal Microbiota in Patients with Hepatitis B Cirrhosis/Liver Fibrosis: A Randomized Double-Blind Controlled Trial
    Xin Chi, Danying Cheng, Xiu Li Sun, Shunai Liu, Rongbin Wang, Qin Chen, Huichun Xing · 2023 · Chinese Journal of Integrative Medicine
  48. Signs of aging in midlife: physical function and sex differences in microbiota
    Roy Tzemah-Shahar, Sondra Turjeman, Efrat Sharon, Gila Gamliel, Hagit Hochner, Omry Koren, Maayan Agmon · 2023 · GeroScience
  49. Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)
    Nelson Kei, Vincent Wai‐Sun Wong, Susana Lauw, Lijun You, Peter Chi Keung Cheung · 2023 · Foods
  50. Composition of gut microbiota and its correlations with neurological, intestinal, cardiovascular and metabolic diseases
    Morena Sciuto, Roberto Catanzaro · 2023 · Acta Microbiologica et Immunologica Hungarica
  51. Western diet components that increase intestinal permeability with implications on health
    Gilberto Jaquez-Durán, Ana Lidia Arellano-Ortiz · 2023 · International Journal for Vitamin and Nutrition Research
  52. Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist
    An-Na Moon, François Briand, Natália Martins Breyner, Dong Keun Song, Martin Rønn Madsen, Hongbin Kim, Keonwoo Choi, Yoonsuk Lee, Wan Namkung · 2024 · Biomedicine & Pharmacotherapy
  53. Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children
    Jiayou Luo, Miyang Luo, Atipatsa Chiwanda Kaminga, Jia Wei, Wen Dai, Yunlong Peng, Kunyan Zhao, Yamei Duan, Xiang Xiao, SiSi Ouyang et al. · 2024 · Microbiology Spectrum
  54. Dual-Stimuli-Responsive Gut Microbiota-Targeting Nitidine Chloride-CS/PT-NPs Improved Metabolic Status in NAFLD
    Jianmei Lu, Yongzhu Zeng, Hanyu Zhong, Wei Guo, Yuyan Zhang, Wanting Mai, Yucui Qin, Xiaodan Su, Bo Zhang, Weisen Wu et al. · 2024 · International Journal of Nanomedicine
  55. Aging Gut Microbiome in Healthy and Unhealthy Aging
    Wang Yangyanqiu, Zhanbo Qu, Jian Chu, Shuwen Han · 2024 · Aging and Disease
  56. Impact of cholecystectomy on the gut-liver axis and metabolic disorders
    Mariana Amaral Raposo, Emília Oliveira, Andrey Santos, Dioze Guadagnini, Haquima El Mourabit, Chantal Housset, Sara Lemoinne, Mário J.A. Saad · 2024 · Clinics and Research in Hepatology and Gastroenterology
  57. A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH
    Justine Gillard, Martin Roumain, Corinne Picalausa, Morgane M. Thibaut, Laure‐Alix Clerbaux, Anne Tailleux, Bart Staels, Giulio G. Muccioli, Laure B. Bindels, Isabelle A. Leclercq · 2024 · JHEP Reports
  58. Soybean oil-based HFD induces gut dysbiosis that leads to steatosis, hepatic inflammation and insulin resistance in mice
    TEXY K. JACOB, Sardar T. A. K. Sindhu, Amal Hasan, Md. Zubbair Malik, Hossein Arefanian, Fatema Al‐Rashed, Rasheeba Nizam, Shihab Kochumon, Reeby Thomas, Fatemah Bahman et al. · 2024 · Frontiers in Microbiology
  59. Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease
    Samradhi Singh, Mona Kriti, Roberto Catanzaro, Francesco Marotta, Mustafa Malvi, Ajay Kumar Jain, Vinod Verma, Ravinder Nagpal, Rajnarayan Ramshankar Tiwari, Manoj Kumar · 2024 · Livers
  60. Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments
    Carlos Jose Pirola, María Silvina Landa, Mariano Luis Schuman, Silvia Inés García, Adrián Salatino, Silvia C. Sookoian · 2024 · Clinical and Molecular Hepatology
  61. Fibrosis and the intestinal microbiome; a focus on chronic liver disease
    Naiara Beraza · 2019 · Current Opinion in Pharmacology
  62. Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis
    Monica A. Tincopa · 2020 · Endocrinology Diabetes & Metabolism
  63. Burn resuscitation strategy influences the gut microbiota-liver axis in swine
    Wayne T. Muraoka, Jose C. Granados, Belinda I. Gómez, Susannah E. Nicholson, Kevin K. Chung, Jeffrey W. Shupp, James A. Bynum, Michael A. Dubick, David Mark Burmeister · 2020 · Scientific Reports
  64. Changes and Correlations of the Intestinal Flora and Liver Metabolite Profiles in Mice With Gallstones
    Yang Chen, Qiang Wang, Wenqi Gao, Biao Ma, Dongbo Xue, Chenjun Hao · 2021 · Frontiers in Physiology
  65. Gut microbiome and metabolic response in non-alcoholic fatty liver disease
    Asmita Madatali Abuwani, Shweta Priyadarshini Dash, Raja Ganesan, Kaviyarasi Renu, Balachandar Vellingiri, Sabariswaran Kandasamy, Sundara Rajan C.R., Abilash Valsala Gopalakrishnan · 2021 · Clinica Chimica Acta
  66. Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis
    Emmanouil Sinakos · 2022 · Annals of Gastroenterology
  67. The Biotics Family: Current Knowledge and Future Perspectives in Metabolic Diseases
    Codrina-Madalina Palade, Georgiana-Anca Vulpoi, Radu Alexandru Vulpoi, Vasile Liviu Drug, Oana-Bogdana Bărboi, Manuela Ciocoiu · 2022 · Life
  68. Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review
    Samuel J. Martínez‐Domínguez, Sandra G. García, Viviana Laredo, Carla J. Gargallo-Puyuelo, Beatriz Gallego Llera, Julia López de la Cruz, Fernando Gomollón · 2023 · Cancers
  69. Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study
    Benedetta Maria Motta, Christoph Grander, Martin Gögele, Luisa Foco, Vladimir Vuković, Roberto Melotti, Christian Fuchsberger, Alessandro De Grandi, Chiara Cantaloni, Anne Picard et al. · 2019 · Journal of Translational Medicine
  70. Nonalcoholic fatty liver disease
    Evangelia S. Makri, Stergios A. Pοlyzos · 2022 · Journal of Atherosclerosis Prevention and Treatment
  71. False ankylosis of the temporomandibular joint in a cat
    Rene T. van Ee, Robert D. Pechman · 1987 · Journal of the American Veterinary Medical Association
  72. Mouse model of NASH that replicates key features of the human disease and progresses to fibrosis stage 3
    St. Rose, Kristy, Yan, Jun, Xu, Fangxi, Williams, Jasmine, Dweck, Virginia, Saxena, Deepak, Schwabe, Robert F., Caviglia, Jorge Matias · 2022 · Hepatology Communications
  73. Association between bowel movement frequency, stool consistency and MAFLD and advanced fibrosis in US adults: a cross-sectional study of NHANES 2005-2010
    Miaomin Ye, Yijia He, Yin Yan Xia, Ziyi Zhong, Xiaocen Kong, Yunting Zhou, Weiping Wang, Suping Qin, Qian Li · 2024 · BMC Gastroenterology
  74. Helicobacter pylori infection and association with chronic diseases: A focus on cardiovascular disease, MASLD, and type 2 diabetes
    N Maleki, Alireza Mohammadzadeh, Jalal Mardaneh, Hossein Pazoki, Elyas Nattagh‐Eshtivani · 2025 · Metabolism Open
  75. Non-Alcoholic Fatty Liver Disease in Poultry: Risk Factors, Mechanism of Development, and Emerging Strategies
    Aneeqa Imtiaz, Muhammad Talha Bin Tahir, Minmeng Zhao, Daoqing Gong, Jing Ge, Tuoyu Geng · 2025 · International Journal of Molecular Sciences
  76. Liver MRI–derived Proton Density Fat Fraction Predicts Diabetes Risk in Patients with Obesity: A Dose-Response Study
    Ming Deng, Zhen Li, Li Sun, Huawei Wang, Jun Tang, Yanxin Liu, Xunuo Chen, Haibo Xu, Zhe Dai · 2025 · Radiology
  77. Implications of the Liver-Gut Axis in Liver Disease: From Mechanisms to Therapeutic Targets
    Mariana Michelle Ramírez-Mejía, Guadalupe Ponciano‐Rodríguez, Nahúm Méndez‐Sánchez · 2025 · Archives of Medical Research
  78. Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities
    Huiping Zhou, Yi Huang, Chen Chen, Meiyi Song, Phillip B. Hylemon · 2026 · Pharmacological Reviews
  79. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG)
    Ricardo Correa Barbuti, Leonardo de Lucca Schiavon, Claudia Pinto Marques Souza de Oliveira, Mário Reis Álvares‐da‐Silva, Lígia Yukie Sassaki, Maria do Carmo Friche Passos, Alberto Queiróz Farias, Luísa Leite Barros, Bruno Acatauassú Paes Barreto, Gisela Bandeira de Melo Lins de Albuquerque et al. · 2020 · Arquivos de Gastroenterologia
  80. Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis
    Larisse Longo, Pabulo Henrique Rampelotto, Eduardo Cremonese Filippi‐Chiela, Valessa Emanoele Gabriel de Souza, Fernando Salvati, Carlos Thadeu Schmidt Cerski, Themis Reverbel da Silveira, Claudia Pinto Marques Souza de Oliveira, Carolina Uribe Cruz, Mário Reis Álvares‐da‐Silva · 2021 · World Journal of Hepatology
  81. Identification of a novel probiotic and its protective effects on NAFLD via modulating gut microbial community
    Weitao Geng, Yang Zhang, H. J. Yang, Jing Zhang, Jingqi Zhao, Jinju Wang, Longgang Jia, Yanping Wang · 2022 · Journal of the Science of Food and Agriculture
  82. Impact of gut microbiota on nonalcoholic fatty liver disease: insights from a leave-one-out cross-validation study
    Tongtong Pan, Lihuang Su, Yiying Zhang, Fangfang Yi, Yong‐Ping Chen · 2024 · Frontiers in Microbiology
  83. The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease
    Carlo Acierno, Riccardo Nevola, Luca Rinaldi, Ferdinando Carlo Sasso, Luigi Elio Adinolfi, Alfredo Caturano · 2025 · Livers
  84. Lactobacillus plantarum 1-2-3 inhibits ferroptosis by regulating dysregulated fatty acid metabolism to protect mice from high-fat diet-induced MAFLD
    Meihua Zhang, Shuo Zhang, Huixian Wu, Laizhi Xu, Peichao Gao, Yixin Gao, Wentao Fan, Suquan Song · 2025 · Free Radical Biology and Medicine
  85. A brief review on the rising incidence of chronic kidney diseases and non-alcoholic fatty liver disease
    Judit Nagy, T Kovács · 2019 · Physiology International
  86. Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery
    Chen Fu, Yong Jian Zhou, Z. Wu, Yunze Li, Wenlong Zhou, Yong Wang · 2021 · Frontiers in Endocrinology
  87. Dysbiosis of gut microbiota after cholecystectomy is associated with non‐alcoholic fatty liver disease in mice
    Qihan Wang, Qi-Fan Lu, Wen-Tao Shao, Zhao-Yan Jiang, Hai Hu · 2021 · FEBS Open Bio
  88. The Apparent Asymmetrical Relationship Between Small Bowel Bacterial Overgrowth, Endotoxemia, and Liver Steatosis and Fibrosis in Cirrhotic and Non-Cirrhotic Patients: A Single-Center Pilot Study
    Emidio Scarpellini, Ludovico Abenavoli, Velia Cassano, Emanuele Rinninella, M. Sorge, F. Capretti, Carlo Rasetti, Gianluca Svegliati‐Baroni, Francesco Luzza, Pierangelo Santori et al. · 2022 · Frontiers in Medicine
  89. The Potential Effect of Chinese Herbal Formula Hongqijiangzhi Fang in Improving NAFLD: Focusing on NLRP3 Inflammasome and Gut Microbiota
    Liang Shu, Yupei Zhang, Yuanjun Deng, Yifang He, Yinji Liang, Zien Liang, Yanning Chen, Kairui Tang, Runsen Chen, Qinhe Yang · 2018 · Evidence-based Complementary and Alternative Medicine
  90. Microbiome
    Bradley Reuter, Jasmohan Singh Bajaj · 2020 · Clinics in Liver Disease
  91. Cross‐linkage between bacterial taxonomy and gene functions: a study of metagenome‐assembled genomes of gut microbiota in adult non‐alcoholic fatty liver disease
    Clémence M. Canivet, Norma David, Hélène Pailhories, Martial Briand, Cynthia D. Guy, Olivier Bouchez, Gilles Hunault, Lionel Fizanne, Adrien Lannes, F. Oberti et al. · 2021 · Alimentary Pharmacology & Therapeutics
  92. The role of bariatric surgery in the management of nonalcoholic steatohepatitis
    Keri A. Seymour, Manal F. Abdelmalek · 2021 · Current Opinion in Gastroenterology
  93. Molecular mechanisms of non-alcoholic fatty liver disease development
    Tatyana S. Sall, Elena S. Shcherbakova, Stanislav I. Sitkin, Timur Vakhitov, Игорь Геннадьевич Бакулин, Elena V. Demyanova · 2021 · Russian Journal of Preventive Medicine
  94. Probiotics and gut health
    Emidio Scarpellini, Martina BASILICO, Emanuele Rinninella, Florencia Carbone, Jolien Schol, Carlo RASETTI, Ludovico Abenavoli, Pierangelo SANTORI · 2021 · Minerva Gastroenterology
  95. Mouse models of nonalcoholic steatohepatitis and their application to new drug development
    Huy Hieu Phung, Chang Hoon Lee · 2022 · Archives of Pharmacal Research
  96. La Estoria de España de Alfonso X: creación y evolución
    Diego Catalán · 1992
  97. Macrophages as a source of fibrosis biomarkers for non-alcoholic fatty liver disease
    Sachiyo Yoshio, Tatsuya Kanto · 2021 · Immunological Medicine
  98. Tartary Buckwheat Flavonoids Relieve Non-alcoholic Fatty Liver Disease by Inhibiting Lipid Accumulation, Inflammation, and Regulating Intestinal Flora
    Ping Xu, Juxiong Liu, Zhe Li, Xingchi Kan, Guiqiu Hu, Yu Cao, Wenjin Guo, Shoupeng Fu · 2023 · Revista Brasileira de Farmacognosia
  99. Gentiopicroside improves high-fat diet-induced NAFLD in association with modulation of host serum metabolome and gut microbiome in mice
    Lijuan Wang, Yuxin Jiang, Qian Yu, Chunping Xiao, Jin Sun, Lili Weng, Ye Qiu · 2023 · Frontiers in Microbiology
  100. Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link
    Maria Effenberger, Christoph Grander, Felix Grabherr, Herbert Tilg · 2023 · Journal of Clinical and Translational Hepatology